Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:53 PM
Ignite Modification Date:
2025-12-24 @ 2:53 PM
NCT ID:
NCT02890459
Eligibility Criteria:
AIM 1 - TESTING TRIAL
Inclusion Criteria:
* Male
* ≥18 years
* Resident (≥6 months) in one of 4 study communities
Exclusion Criteria:
* Plan to move \<6 months from study start
AIM 2 - TREATMENT TRIAL
Inclusion Criteria:
* ≥18 years
* Resident (≥6 months) in one of 4 study communities
* HIV positive
Exclusion Criteria:
* Plan to move \<6 months from study start
AIM 3 - REPEAT TESTING PILOT
Inclusion Criteria:
* HIV-negative by rapid HIV antibody testing at pilot trial baseline,
* Ages 18 - 59 years old,
* Attendee of high-risk site of HIV acquisition (e.g. bars, trading centers, etc.) in the region
Exclusion Criteria:
* Intention to move away from the community in the 3 months from time of recruitment
AIM 3 - REPEAT TESTING TRIAL
Inclusion Criteria:
* HIV-negative by rapid HIV antibody testing at time of recruitment,
* Ages 18 - 59 years old,
* Reported willingness to retest for HIV in the six months following recruitment,
* Sexual risk behavior, defined as at least one of the following self-reported risks in the 12 months prior to recruitment:
1. \>1 sexual partner, or
2. known HIV-infected sexual partner, or
3. sexually transmitted infection, or
4. paid or received compensation or gifts for sex.
Exclusion Criteria:
* Intention to move away from the community for \>=4 consecutive months during the six months following recruitment
* A history of testing for HIV \>=3 times in the 12 months prior to recruitment
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02890459
Study Brief:
Protocol Section:
NCT02890459